Intra-Cellular Therapies's total assets for Q4 2024 were $1.37B, an increase of 3.21% from the previous quarter. ITCI total liabilities were $218.45M for the fiscal quarter, a 21.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.